Literature DB >> 19898434

Genzyme backs Osiris, despite Prochymal flop.

Malorye Allison.   

Abstract

Mesh：

Year:  2009        PMID： 19898434     DOI： 10.1038/nbt1109-966

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  2 in total

1.  Osiris seals billion-dollar deal with Genzyme for cell therapy.

Authors:  George S Mack
Journal:  Nat Biotechnol       Date:  2009-02       Impact factor: 54.908

2.  Mesenchymal stem cells as cellular immunosuppressants.

Authors:  Dominik Wolf; Anna Maria Wolf
Journal:  Lancet       Date:  2008-05-10       Impact factor: 79.321
  2 in total
  37 in total

Review 1.  Immune modulation of inflammatory conditions: regulatory T cells for treatment of GvHD.

Authors:  Doreen Haase; Mireille Starke; Kia Joo Puan; Tuck Siong Lai; Olaf Rotzschke
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

Review 2.  Prevention of graft-vs.-host disease.

Authors:  Andrew R Rezvani; Rainer F Storb
Journal:  Expert Opin Pharmacother       Date:  2012-07-07       Impact factor: 3.889

3.  Donor variability among anti-inflammatory pre-activated mesenchymal stromal cells.

Authors:  Andrea Gray; Rene S Schloss; Martin Yarmush
Journal:  Technology (Singap World Sci)       Date:  2016-09

4.  Primary marrow-derived stromal cells: isolation and manipulation.

Authors:  Aravind Ramakrishnan; Beverly Torok-Storb; Manoj M Pillai
Journal:  Methods Mol Biol       Date:  2013

5.  Cephalon splashes out on mesenchymal stem cells.

Authors: 
Journal:  Nat Biotechnol       Date:  2011-02       Impact factor: 54.908

Review 6.  Interactions between mesenchymal stem cells and the immune system.

Authors:  Na Li; Jinlian Hua
Journal:  Cell Mol Life Sci       Date:  2017-02-18       Impact factor: 9.261

7.  Mesenchymal stem cells are injured by complement after their contact with serum.

Authors:  Yan Li; Feng Lin
Journal:  Blood       Date:  2012-09-10       Impact factor: 22.113

8.  Synergistic and Superimposed Effect of Bone Marrow-Derived Mesenchymal Stem Cells Combined with Fasudil in Experimental Autoimmune Encephalomyelitis.

Authors:  Jing-Wen Yu; Yan-Hua Li; Guo-Bin Song; Jie-Zhong Yu; Chun-Yun Liu; Jian-Chun Liu; Hai-Fei Zhang; Wan-Fang Yang; Qing Wang; Ya-Ping Yan; Bao-Guo Xiao; Cun-Gen Ma
Journal:  J Mol Neurosci       Date:  2016-08-30       Impact factor: 3.444

Review 9.  Mesenchymal stem cell treatments in rheumatology: a glass half full?

Authors:  Alan Tyndall
Journal:  Nat Rev Rheumatol       Date:  2013-11-12       Impact factor: 20.543

10.  Activation of Toll-like receptor 3 amplifies mesenchymal stem cell trophic factors and enhances therapeutic potency.

Authors:  Michalis Mastri; Zaeem Shah; Terence McLaughlin; Christopher J Greene; Leah Baum; Gen Suzuki; Techung Lee
Journal:  Am J Physiol Cell Physiol       Date:  2012-07-25       Impact factor: 4.249
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.